Ghrelin

Molecular Metabolism

Volumn 4, Issue 6, 2015, Pages 437-460

  Muller T D ^a   Nogueiras, R ^b   Andermann, M L ^c   Andrews, Z B ^d   Anker, S D ^e   Argente, J ^f,g   Batterham, R L ^h   Benoit, S C ⁱ   Bowers, C Y ^j   Broglio, F ^k   Casanueva, F F ^l   D'Alessio, D ^m   Depoortere, I ⁿ   Geliebter, A ^o   Ghigo, E ^p   Cole, P A ^d   Cowley, M ^d   Cummings, D E ^q   Dagher, A ^r   Diano, S ^s   Dickson, S L ^t   Dieguez C ^u   Granata, R ^k   Grill, H J ^v   Grove, K ^w   Habegger, K M ^x   Heppner, K ^w   Heiman, M L ^y   Holsen, L ^z   Holst, B ^aa   Inui, A ^ab   Jansson, J O ^t   Kirchner, H ^ac   Korbonits, M ^ad   Laferrere B ^o   LeRoux, C W ^ae   Lopez, M ^b   Morin, S ^a   Nakazato, M ^af   Nass, R ^ag   Perez Tilve, D ⁱ   Pfluger, P T ^a   Schwartz, T W ^ah   Seeley, R J ^ai   Sleeman, M ^d   Sun, Y ^aj   Sussel, L ^ak   Tong, J ^m   Thorner, M O ^ag   van der Lely, A J ^al   van der Ploeg, L H T ^am   Zigman, J M ^an   Kojima, M ^ao   Kangawa, K ^ap   Smith, R G ^aq   Horvath, T ^s   Tschop M H ^a,ar   more..

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b Univ of Santiago de Compostela ^*  (Spain)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d MONASH UNIVERSITY   (Australia)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^g INSTITUTO DE SALUD CARLOS III   (Spain)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^j TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^k UNIVERSITY OF TURIN   (Italy)

^l HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^m DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ UNIVERSITY OF LEUVEN   (Belgium)

^o Columbia University College of Physicians and Surgeons ^*  (United States)

^p JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^q UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^r MCGILL UNIVERSITY   (Canada)

^s YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^t UNIVERSITY OF GOTHENBURG   (Sweden)

^u UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^v UNIVERSITY OF PENNSYLVANIA   (United States)

^w OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^x UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^y NuMe Health   (United States)

^z BRIGHAM AND WOMEN S HOSPITAL   (United States)

^aa UNIVERSITY OF COPENHAGEN   (Denmark)

^ab KAGOSHIMA UNIVERSITY   (Japan)

^ac UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^ad QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^ae UNIVERSITY COLLEGE DUBLIN   (Ireland)

^af UNIVERSITY OF MIYAZAKI   (Japan)

^ag UNIVERSITY OF VIRGINIA   (United States)

^ah UNIVERSITY OF COPENHAGEN   (Denmark)

^ai UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^aj BAYLOR COLLEGE OF MEDICINE   (United States)

^ak Och Spine at New York Presbyterian Hospitals   (United States)

^al ERASMUS MEDICAL CENTER   (Netherlands)

^am Rhythm Pharmaceuticals   (United States)

^an UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^ao KURUME UNIVERSITY   (Japan)

^ap NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^aq SCRIPPS RESEARCH INSTITUTE   (United States)

^ar TECHNICAL UNIVERSITY OF MUNICH   (Germany)

more..

Author keywords

Ghrelin; Growth hormone segretagogue receptor

Indexed keywords

ACYLTRANSFERASE; AGOUTI RELATED PROTEIN; ANAMORELIN; CARPROMORELIN; GHRELIN; GHRELIN ACYLTRANSFERASE; GHRELIN RECEPTOR; GLUCOSE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE RELEASING FACTOR DERIVATIVE; HEXARELIN; IBUTAMOREN; IPAMORELIN; LY 426410; LY 444711; MACIMORELIN; NEUROPEPTIDE Y; OPIATE; PRALMORELIN; PROTEIN C FOS; RELAMORELIN; SM 130686; ULIMORELIN; UNCLASSIFIED DRUG;

ACYLATION; ADENOHYPOPHYSIS; ANOREXIA; BARIATRIC SURGERY; CACHEXIA; CONSTIPATION; DIABETIC STOMACH PARESIS; DRUG TARGETING; ENERGY METABOLISM; FOOD INTAKE; FRAIL ELDERLY; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MOTILITY; GLUCOSE METABOLISM; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONE RELEASE; HUMAN; HUNGER; LEARNING; MEMORY CONSOLIDATION; METABOLIC REGULATION; NONHUMAN; OBESITY; OPIOID INDUCED CONSTIPATION; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; REWARD; SATIETY; SLEEP WAKING CYCLE; STOMACH ACID SECRETION; TASTE;

EID: 84929964936     PISSN: None     EISSN: 22128778     Source Type: Journal    
DOI: 10.1016/j.molmet.2015.03.005     Document Type: Review

References (359)

1. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
2. Tschop M., Smiley D.L., Heiman M.L. Ghrelin induces adiposity in rodents. Nature 2000, 407:908-913.
3. Cowley M.A., Smith R.G., Diano S., Tschop M., Pronchuk N., Grove K.L., et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003, 37:649-661.
4. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., et al. Arole for ghrelin in the central regulation of feeding. Nature 2001, 409:194-198.
5. Masuda Y., Tanaka T., Inomata N., Ohnuma N., Tanaka S., Itoh Z., et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochemical and Biophysical Research Communications 2000, 276:905-908.
6. Asakawa A., Inui A., Kaga T., Yuzuriha H., Nagata T., Ueno N., et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 2001, 120:337-345.
7. Tolle V., Bassant M.H., Zizzari P., Poindessous-Jazat F., Tomasetto C., Epelbaum J., et al. Ultradian rhythmicity of ghrelin secretion in relation with GH, feeding behavior, and sleep-wake patterns in rats. Endocrinology 2002, 143:1353-1361.
8. Weikel J.C., Wichniak A., Ising M., Brunner H., Friess E., Held K., et al. Ghrelin promotes slow-wave sleep in humans. American Journal of Physiology Endocrinology and Metabolism 2003, 284:E407-E415.
9. Szentirmai E., Hajdu I., Obal F., Krueger J.M. Ghrelin-induced sleep responses in ad libitum fed and food-restricted rats. Brain Research 2006, 1088:131-140.
10. Cai H., Cong W.N., Daimon C.M., Wang R., Tschop M.H., Sevigny J., et al. Altered lipid and salt taste responsivity in ghrelin and GOAT null mice. PloS One 2013, 8:e76553.
11. Druce M.R., Wren A.M., Park A.J., Milton J.E., Patterson M., Frost G., et al. Ghrelin increases food intake in obese as well as lean subjects. International Journal of Obesity (London) 2005, 29:1130-1136.
12. Jerlhag E., Egecioglu E., Dickson S.L., Andersson M., Svensson L., Engel J.A. Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward. Addiction Biology 2006, 11:45-54.
13. Jerlhag E., Egecioglu E., Dickson S.L., Douhan A., Svensson L., Engel J.A. Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens. Addiction Biology 2007, 12:6-16.
14. Overduin J., Figlewicz D.P., Bennett-Jay J., Kittleson S., Cummings D.E. Ghrelin increases the motivation to eat, but does not alter food palatability. American Journal of Physiology Regulatory, Integrative and Comparative Physiology 2012, 303:R259-R269.
15. Skibicka K.P., Hansson C., Egecioglu E., Dickson S.L. Role of ghrelin in food reward: impact of ghrelin on sucrose self-administration and mesolimbic dopamine and acetylcholine receptor gene expression. Addiction Biology 2012, 17:95-107.
16. Tong J., Mannea E., Aime P., Pfluger P.T., Yi C.X., Castaneda T.R., et al. Ghrelin enhances olfactory sensitivity and exploratory sniffing in rodents and humans. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2011, 31:5841-5846.
17. Date Y., Nakazato M., Hashiguchi S., Dezaki K., Mondal M.S., Hosoda H., et al. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes 2002, 51:124-129.
18. Reed J.A., Benoit S.C., Pfluger P.T., Tschop M.H., D'Alessio D.A., Seeley R.J. Mice with chronically increased circulating ghrelin develop age-related glucose intolerance. American Journal of Physiology Endocrinology and Metabolism 2008, 294:E752-E760.
19. Wortley K.E., del Rincon J.P., Murray J.D., Garcia K., Iida K., Thorner M.O., et al. Absence of ghrelin protects against early-onset obesity. The Journal of Clinical Investigation 2005, 115:3573-3578.
20. Zhao T.J., Liang G., Li R.L., Xie X., Sleeman M.W., Murphy A.J., et al. Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:7467-7472.
21. Yasuda T., Masaki T., Kakuma T., Yoshimatsu H. Centrally administered ghrelin suppresses sympathetic nerve activity in brown adipose tissue of rats. Neuroscience Letters 2003, 349:75-78.
22. Tsubone T., Masaki T., Katsuragi I., Tanaka K., Kakuma T., Yoshimatsu H. Ghrelin regulates adiposity in white adipose tissue and UCP1 mRNA expression in brown adipose tissue in mice. Regulatory Peptides 2005, 130:97-103.
23. Mano-Otagiri A., Ohata H., Iwasaki-Sekino A., Nemoto T., Shibasaki T. Ghrelin suppresses noradrenaline release in the brown adipose tissue of rats. The Journal of Endocrinology 2009, 201:341-349.
24. Mano-Otagiri A., Iwasaki-Sekino A., Nemoto T., Ohata H., Shuto Y., Nakabayashi H., et al. Genetic suppression of ghrelin receptors activates brown adipocyte function and decreases fat storage in rats. Regulatory Peptides 2010, 160:81-90.
25. Lin L., Saha P.K., Ma X., Henshaw I.O., Shao L., Chang B.H., et al. Ablation of ghrelin receptor reduces adiposity and improves insulin sensitivity during aging by regulating fat metabolism in white and brown adipose tissues. Aging Cell 2011, 10:996-1010.
26. Lutter M., Sakata I., Osborne-Lawrence S., Rovinsky S.A., Anderson J.G., Jung S., et al. The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nature Neuroscience 2008, 11:752-753.
27. Spencer S.J., Xu L., Clarke M.A., Lemus M., Reichenbach A., Geenen B., et al. Ghrelin regulates the hypothalamic-pituitary-adrenal axis and restricts anxiety after acute stress. Biological Psychiatry 2012, 72:457-465.
28. Chuang J.C., Perello M., Sakata I., Osborne-Lawrence S., Savitt J.M., Lutter M., et al. Ghrelin mediates stress-induced food-reward behavior in mice. The Journal of Clinical Investigation 2011, 121:2684-2692.
29. Filigheddu N., Gnocchi V.F., Coscia M., Cappelli M., Porporato P.E., Taulli R., et al. Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells. Molecular Biology of the Cell 2007, 18:986-994.
30. Porporato P.E., Filigheddu N., Reano S., Ferrara M., Angelino E., Gnocchi V.F., et al. Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice. The Journal of Clinical Investigation 2013, 123:611-622.
31. Rizzo M., Rizvi A.A., Sudar E., Soskic S., Obradovic M., Montalto G., et al. Areview of the cardiovascular and anti-atherogenic effects of Ghrelin. Current Pharmaceutical Design 2013, 19:4953-4963.
32. Nagaya N., Uematsu M., Kojima M., Ikeda Y., Yoshihara F., Shimizu W., et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 2001, 104:1430-1435.
33. Okumura H., Nagaya N., Enomoto M., Nakagawa E., Oya H., Kangawa K. Vasodilatory effect of ghrelin, an endogenous peptide from the stomach. Journal of Cardiovascular Pharmacology 2002, 39:779-783.
34. Nagaya N., Moriya J., Yasumura Y., Uematsu M., Ono F., Shimizu W., et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 2004, 110:3674-3679.
35. Cummings D.E. Ghrelin and the short- and long-term regulation of appetite and body weight. Physiology & Behavior 2006, 89:71-84.
36. Cummings D.E., Frayo R.S., Marmonier C., Aubert R., Chapelot D. Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues. American Journal of Physiology Endocrinology and Metabolism 2004, 287:E297-E304.
37. Cummings D.E., Purnell J.Q., Frayo R.S., Schmidova K., Wisse B.E., Weigle D.S. Apreprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001, 50:1714-1719.
38. Kojima M., Kangawa K. Ghrelin: structure and function. Physiological Reviews 2005, 85:495-522.
39. Tschop M., Wawarta R., Riepl R.L., Friedrich S., Bidlingmaier M., Landgraf R., et al. Post-prandial decrease of circulating human ghrelin levels. Journal of Endocrinological Investigation 2001, 24:RC19-21.
40. Guan X.M., Yu H., Palyha O.C., McKee K.K., Feighner S.D., Sirinathsinghji D.J., et al. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Research Molecular Brain Research 1997, 48:23-29.
41. Dickson S.L., Luckman S.M. Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6. Endocrinology 1997, 138:771-777.
42. Willesen M.G., Kristensen P., Romer J. Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology 1999, 70:306-316.
43. Bowers C.Y., Momany F., Reynolds G.A., Chang D., Hong A., Chang K. Structure-activity relationships of a synthetic pentapeptide that specifically releases growth hormone invitro. Endocrinology 1980, 106:663-667.
44. Momany F.A., Bowers C.Y., Reynolds G.A., Chang D., Hong A., Newlander K. Design, synthesis, and biological activity of peptides which release growth hormone invitro. Endocrinology 1981, 108:31-39.
45. Smith R.G., Van der Ploeg L.H., Howard A.D., Feighner S.D., Cheng K., Hickey G.J., et al. Peptidomimetic regulation of growth hormone secretion. Endocrine Reviews 1997, 18:621-645.
46. Dickson S.L., Leng G., Robinson I.C. Systemic administration of growth hormone-releasing peptide activates hypothalamic arcuate neurons. Neuroscience 1993, 53:303-306.
47. Blake A.D., Smith R.G. Desensitization studies using perifused rat pituitary cells show that growth hormone-releasing hormone and His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 stimulate growth hormone release through distinct receptor sites. The Journal of Endocrinology 1991, 129:11-19.
48. Bowers C.Y., Reynolds G.A., Durham D., Barrera C.M., Pezzoli S.S., Thorner M.O. Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. The Journal of Clinical Endocrinology and Metabolism 1990, 70:975-982.
49. Cheng K., Chan W.W., Butler B., Barreto A., Smith R.G. Evidence for a role of protein kinase-C in His-D-Trp-Ala-Trp-D-Phe-Lys-NH2-induced growth hormone release from rat primary pituitary cells. Endocrinology 1991, 129:3337-3342.
50. Howard A.D., Feighner S.D., Cully D.F., Arena J.P., Liberator P.A., Rosenblum C.I., et al. Areceptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996, 273:974-977.
51. Gnanapavan S., Kola B., Bustin S.A., Morris D.G., McGee P., Fairclough P., et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. The Journal of Clinical Endocrinology and Metabolism 2002, 87:2988.
52. Jiang H., Betancourt L., Smith R.G. Ghrelin amplifies dopamine signaling by cross talk involving formation of growth hormone secretagogue receptor/dopamine receptor subtype 1 heterodimers. Molecular Endocrinology 2006, 20:1772-1785.
53. Leung P.K., Chow K.B., Lau P.N., Chu K.M., Chan C.B., Cheng C.H., et al. The truncated ghrelin receptor polypeptide (GHS-R1b) acts as a dominant-negative mutant of the ghrelin receptor. Cellular Signalling 2007, 19:1011-1022.
54. Zhang J.V., Ren P.G., Avsian-Kretchmer O., Luo C.W., Rauch R., Klein C., et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005, 310:996-999.
55. Depoortere I. GI functions of GPR39: novel biology. Current Opinion in Pharmacology 2012, 12:647-652.
56. Gutierrez J.A., Solenberg P.J., Perkins D.R., Willency J.A., Knierman M.D., Jin Z., et al. Ghrelin octanoylation mediated by an orphan lipid transferase. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:6320-6325.
57. Yang J., Brown M.S., Liang G., Grishin N.V., Goldstein J.L. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 2008, 132:387-396.
58. Sakata I., Yang J., Lee C.E., Osborne-Lawrence S., Rovinsky S.A., Elmquist J.K., et al. Colocalization of ghrelin O-acyltransferase and ghrelin in gastric mucosal cells. American Journal of Physiology Endocrinology and Metabolism 2009, 297:E134-E141.
59. Lim C.T., Kola B., Grossman A., Korbonits M. The expression of ghrelin O-acyltransferase (GOAT) in human tissues. Endocrine Journal 2011, 58:707-710.
60. Barnett B.P., Hwang Y., Taylor M.S., Kirchner H., Pfluger P.T., Bernard V., et al. Glucose and weight control in mice with a designed ghrelin O-acyltransferase inhibitor. Science 2010, 330:1689-1692.
61. Kirchner H., Gutierrez J.A., Solenberg P.J., Pfluger P.T., Czyzyk T.A., Willency J.A., et al. GOAT links dietary lipids with the endocrine control of energy balance. Nature Medicine 2009, 15:741-745.
62. Yang J., Zhao T.J., Goldstein J.L., Brown M.S. Inhibition of ghrelin O-acyltransferase (GOAT) by octanoylated pentapeptides. Proceedings of theNational Academy of Sciences of the United States of America 2008, 105:10750-10755.
63. Nishi Y., Hiejima H., Hosoda H., Kaiya H., Mori K., Fukue Y., et al. Ingested medium-chain fatty acids are directly utilized for the acyl modification of ghrelin. Endocrinology 2005, 146:2255-2264.
64. Sakata I., Nakamura K., Yamazaki M., Matsubara M., Hayashi Y., Kangawa K., et al. Ghrelin-producing cells exist as two types of cells, closed- and opened-type cells, in the rat gastrointestinal tract. Peptides 2002, 23:531-536.
65. Armand M., Hamosh M., Mehta N.R., Angelus P.A., Philpott J.R., Henderson T.R., et al. Effect of human milk or formula on gastric function and fat digestion in the premature infant. Pediatric Research 1996, 40:429-437.
66. Heppner K.M., Chaudhary N., Muller T.D., Kirchner H., Habegger K.M., Ottaway N., et al. Acylation type determines ghrelin's effects on energy homeostasis in rodents. Endocrinology 2012, 153:4687-4695.
67. Ohgusu H., Shirouzu K., Nakamura Y., Nakashima Y., Ida T., Sato T., et al. Ghrelin O-acyltransferase (GOAT) has a preference for n-hexanoyl-CoA over n-octanoyl-CoA as an acyl donor. Biochemical and Biophysical Research Communications 2009, 386:153-158.
68. Janssen S., Laermans J., Iwakura H., Tack J., Depoortere I. Sensing of fatty acids for octanoylation of ghrelin involves a gustatory G-protein. PloS One 2012, 7:e40168.
69. Takaya K., Ariyasu H., Kanamoto N., Iwakura H., Yoshimoto A., Harada M., et al. Ghrelin strongly stimulates growth hormone release in humans. The Journal of Clinical Endocrinology and Metabolism 2000, 85:4908-4911.
70. Arvat E., Maccario M., Di Vito L., Broglio F., Benso A., Gottero C., et al. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. The Journal of Clinical Endocrinology and Metabolism 2001, 86:1169-1174.
71. Nagaya N., Kojima M., Uematsu M., Yamagishi M., Hosoda H., Oya H., et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. American Journal of Physiology Regulatory, Integrative and Comparative Physiology 2001, 280:R1483-R1487.
72. Hataya Y., Akamizu T., Takaya K., Kanamoto N., Ariyasu H., Saijo M., et al. Alow dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. The Journal of Clinical Endocrinology and Metabolism 2001, 86:4552.
73. Mericq V., Cassorla F., Bowers C.Y., Avila A., Gonen B., Merriam G.R. Changes in appetite and body weight in response to long-term oral administration of the ghrelin agonist GHRP-2 in growth hormone deficient children. Journal of Pediatric Endocrinology & Metabolism: JPEM 2003, 16:981-985.
74. Schmid D.A., Held K., Ising M., Uhr M., Weikel J.C., Steiger A. Ghrelin stimulates appetite, imagination of food, GH, ACTH, and cortisol, but does not affect leptin in normal controls. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2005, 30:1187-1192.
75. Hotta M., Ohwada R., Akamizu T., Shibasaki T., Takano K., Kangawa K. Ghrelin increases hunger and food intake in patients with restricting-type anorexia nervosa: a pilot study. Endocrine Journal 2009, 56:1119-1128.
76. Wynne K., Giannitsopoulou K., Small C.J., Patterson M., Frost G., Ghatei M.A., et al. Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial. Journal of the American Society of Nephrology: JASN 2005, 16:2111-2118.
77. Ashby D.R., Ford H.E., Wynne K.J., Wren A.M., Murphy K.G., Busbridge M., et al. Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment. Kidney International 2009, 76:199-206.
78. Nagaya N., Itoh T., Murakami S., Oya H., Uematsu M., Miyatake K., et al. Treatment of cachexia with ghrelin in patients with COPD. Chest 2005, 128:1187-1193.
79. Neary N.M., Small C.J., Wren A.M., Lee J.L., Druce M.R., Palmieri C., et al. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. The Journal of Clinical Endocrinology and Metabolism 2004, 89:2832-2836.
80. Nass R., Pezzoli S.S., Oliveri M.C., Patrie J.T., Harrell F.E., Clasey J.L., et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Annals of Internal Medicine 2008, 149:601-611.
81. Ravussin E., Tschop M., Morales S., Bouchard C., Heiman M.L. Plasma ghrelin concentration and energy balance: overfeeding and negative energy balance studies in twins. The Journal of Clinical Endocrinology and Metabolism 2001, 86:4547-4551.
82. Lejeune M.P., Westerterp K.R., Adam T.C., Luscombe-Marsh N.D., Westerterp-Plantenga M.S. Ghrelin and glucagon-like peptide 1 concentrations, 24-h satiety, and energy and substrate metabolism during a high-protein diet and measured in a respiration chamber. The American Journal of Clinical Nutrition 2006, 83:89-94.
83. Huda M.S., Dovey T., Wong S.P., English P.J., Halford J., McCulloch P., et al. Ghrelin restores 'lean-type' hunger and energy expenditure profiles in morbidly obese subjects but has no effect on postgastrectomy subjects. International Journal of Obesity (London) 2009, 33:317-325.
84. Broglio F., Arvat E., Benso A., Gottero C., Muccioli G., Papotti M., et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. The Journal of Clinical Endocrinology and Metabolism 2001, 86:5083-5086.
85. Broglio F., Gottero C., Benso A., Prodam F., Destefanis S., Gauna C., et al. Effects of ghrelin on the insulin and glycemic responses to glucose, arginine, or free fatty acids load in humans. The Journal of Clinical Endocrinology and Metabolism 2003, 88:4268-4272.
86. Egido E.M., Rodriguez-Gallardo J., Silvestre R.A., Marco J. Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion. European Journal of Endocrinology/European Federation of Endocrine Societies 2002, 146:241-244.
87. Fusco A., Bianchi A., Mancini A., Milardi D., Giampietro A., Cimino V., et al. Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome. Journal of Endocrinological Investigation 2007, 30:948-956.
88. Guido M., Romualdi D., De Marinis L., Porcelli T., Giuliani M., Costantini B., et al. Administration of exogenous ghrelin in obese patients with polycystic ovary syndrome: effects on plasma levels of growth hormone, glucose, and insulin. Fertility and Sterility 2007, 88:125-130.
89. Tassone F., Broglio F., Destefanis S., Rovere S., Benso A., Gottero C., et al. Neuroendocrine and metabolic effects of acute ghrelin administration in human obesity. The Journal of Clinical Endocrinology and Metabolism 2003, 88:5478-5483.
90. Falken Y., Hellstrom P.M., Sanger G.J., Dewit O., Dukes G., Gryback P., et al. Actions of prolonged ghrelin infusion on gastrointestinal transit and glucose homeostasis in humans. Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society 2010, 22:e192-200.
91. Murray C.D., Martin N.M., Patterson M., Taylor S.A., Ghatei M.A., Kamm M.A., et al. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut 2005, 54:1693-1698.
92. Tack J., Depoortere I., Bisschops R., Delporte C., Coulie B., Meulemans A., et al. Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut 2006, 55:327-333.
93. Van der Ploeg L., Laken H., Sharma S., Datta R., Halem H., Dong J., et al. Preclinical gastrointestinal prokinetic efficacy and endocrine effects of the ghrelin mimetic RM-131. Life Sciences 2014, 109:20-29.
94. Wren A.M., Seal L.J., Cohen M.A., Brynes A.E., Frost G.S., Murphy K.G., et al. Ghrelin enhances appetite and increases food intake in humans. The Journal of Clinical Endocrinology and Metabolism 2001, 86:5992.
95. Holsen L.M., Lawson E.A., Christensen K., Klibanski A., Goldstein J.M. Abnormal relationships between the neural response to high- and low-calorie foods and endogenous acylated ghrelin in women with active and weight-recovered anorexia nervosa. Psychiatry Research 2014, 223:94-103.
96. Kroemer N.B., Krebs L., Kobiella A., Grimm O., Pilhatsch M., Bidlingmaier M., et al. Fasting levels of ghrelin covary with the brain response to food pictures. Addiction Biology 2012, 8:855-862.
97. Malik S., McGlone F., Bedrossian D., Dagher A. Ghrelin modulates brain activity in areas that control appetitive behavior. Cell metabolism 2008, 7:400-409.
98. Goldstone A.P., Prechtl C.G., Scholtz S., Miras A.D., Chhina N., Durighel G., et al. Ghrelin mimics fasting to enhance human hedonic, orbitofrontal cortex, and hippocampal responses to food. The American Journal of Clinical Nutrition 2014, 99:1319-1330.
99. Arvat E., Di Vito L., Broglio F., Papotti M., Muccioli G., Dieguez C., et al. Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. Journal of Endocrinological Investigation 2000, 23:493-495.
100. Peino R., Baldelli R., Rodriguez-Garcia J., Rodriguez-Segade S., Kojima M., Kangawa K., et al. Ghrelin-induced growth hormone secretion in humans. European Journal of Endocrinology/European Federation of Endocrine Societies 2000, 143:R11-R14.
101. Veldhuis J.D., Reynolds G.A., Iranmanesh A., Bowers C.Y. Twenty-four hour continuous ghrelin infusion augments physiologically pulsatile, nycthemeral, and entropic (feedback-regulated) modes of growth hormone secretion. The Journal of Clinical Endocrinology and Metabolism 2008, 93:3597-3603.
102. Pantel J., Legendre M., Cabrol S., Hilal L., Hajaji Y., Morisset S., et al. Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. The Journal of Clinical Investigation 2006, 116:760-768.
103. Lango Allen H., Estrada K., Lettre G., Berndt S.I., Weedon M.N., Rivadeneira F., et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010, 467:832-838.
104. Liu B., Garcia E.A., Korbonits M. Genetic studies on the ghrelin, growth hormone secretagogue receptor (GHSR) and ghrelin O-acyl transferase (GOAT) genes. Peptides 2011, 32:2191-2207.
105. Lanfranco F., Bonelli L., Baldi M., Me E., Broglio F., Ghigo E. Acylated ghrelin inhibits spontaneous luteinizing hormone pulsatility and responsiveness to naloxone but not that to gonadotropin-releasing hormone in young men: evidence for a central inhibitory action of ghrelin on the gonadal axis. The Journal of Clinical Endocrinology and Metabolism 2008, 93:3633-3639.
106. Patchett A.A., Nargund R.P., Tata J.R., Chen M.H., Barakat K.J., Johnston D.B., et al. Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:7001-7005.
107. Popovic V., Leal A., Micic D., Koppeschaar H.P., Torres E., Paramo C., et al. GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults. Lancet 2000, 356:1137-1142.
108. Ueberberg B., Unger N., Saeger W., Mann K., Petersenn S. Expression of ghrelin and its receptor in human tissues. Hormone and Metabolic Research= Hormon- und Stoffwechselforschung= Hormones et metabolisme 2009, 41:814-821.
109. Hou Z., Miao Y., Gao L., Pan H., Zhu S. Ghrelin-containing neuron in cerebral cortex and hypothalamus linked with the DVC of brainstem in rat. Regulatory Peptides 2006, 134:126-131.
110. Palus S., Schur R., Akashi Y.J., Bockmeyer B., Datta R., Halem H., et al. Ghrelin and its analogues, BIM-28131 and BIM-28125, improve body weight and regulate the expression of MuRF-1 and MAFbx in a rat heart failure model. PloS One 2011, 6:e26865.
111. Korbonits M., Kojima M., Kangawa K., Grossman A.B. Presence of ghrelin in normal and adenomatous human pituitary. Endocrine 2001, 14:101-104.
112. Korbonits M., Bustin S.A., Kojima M., Jordan S., Adams E.F., Lowe D.G., et al. The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. The Journal of Clinical Endocrinology and Metabolism 2001, 86:881-887.
113. Volante M., Allia E., Fulcheri E., Cassoni P., Ghigo E., Muccioli G., et al. Ghrelin in fetal thyroid and follicular tumors and cell lines: expression and effects on tumor growth. The American Journal of Pathology 2003, 162:645-654.
114. Volante M., Fulcheri E., Allia E., Cerrato M., Pucci A., Papotti M. Ghrelin expression in fetal, infant, and adult human lung. The Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 2002, 50:1013-1021.
115. Granata R., Isgaard J., Alloatti G., Ghigo E. Cardiovascular actions of the ghrelin gene-derived peptides and growth hormone-releasing hormone. Experimental Biology and Medicine (Maywood) 2011, 236:505-514.
116. Beiras-Fernandez A., Kreth S., Weis F., Ledderose C., Pottinger T., Dieguez C., et al. Altered myocardial expression of ghrelin and its receptor (GHSR-1a) in patients with severe heart failure. Peptides 2010, 31:2222-2228.
117. Chuang J.C., Sakata I., Kohno D., Perello M., Osborne-Lawrence S., Repa J.J., et al. Ghrelin directly stimulates glucagon secretion from pancreatic alpha-cells. Molecular Endocrinology 2011, 25:1600-1611.
118. Reimer M.K., Pacini G., Ahren B. Dose-dependent inhibition by ghrelin of insulin secretion in the mouse. Endocrinology 2003, 144:916-921.
119. Dezaki K., Hosoda H., Kakei M., Hashiguchi S., Watanabe M., Kangawa K., et al. Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in beta-cells: implication in the glycemic control in rodents. Diabetes 2004, 53:3142-3151.
120. Salehi A., Dornonville de la Cour C., Hakanson R., Lundquist I. Effects of ghrelin on insulin and glucagon secretion: a study of isolated pancreatic islets and intact mice. Regulatory Peptides 2004, 118:143-150.
121. Qader S.S., Lundquist I., Ekelund M., Hakanson R., Salehi A. Ghrelin activates neuronal constitutive nitric oxide synthase in pancreatic islet cells while inhibiting insulin release and stimulating glucagon release. Regulatory Peptides 2005, 128:51-56.
122. Dezaki K., Sone H., Koizumi M., Nakata M., Kakei M., Nagai H., et al. Blockade of pancreatic islet-derived ghrelin enhances insulin secretion to prevent high-fat diet-induced glucose intolerance. Diabetes 2006, 55:3486-3493.
123. Flanagan D.E., Evans M.L., Monsod T.P., Rife F., Heptulla R.A., Tamborlane W.V., et al. The influence of insulin on circulating ghrelin. American Journal of Physiology Endocrinology and Metabolism 2003, 284:E313-E316.
124. Tong J., Prigeon R.L., Davis H.W., Bidlingmaier M., Kahn S.E., Cummings D.E., et al. Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans. Diabetes 2010, 59:2145-2151.
125. Dezaki K., Kakei M., Yada T. Ghrelin uses Galphai2 and activates voltage-dependent K+ channels to attenuate glucose-induced Ca2+ signaling and insulin release in islet beta-cells: novel signal transduction of ghrelin. Diabetes 2007, 56:2319-2327.
126. Park S., Jiang H., Zhang H., Smith R.G. Modification of ghrelin receptor signaling by somatostatin receptor-5 regulates insulin release. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:19003-19008.
127. Adeghate E., Ponery A.S. Ghrelin stimulates insulin secretion from the pancreas of normal and diabetic rats. Journal of Neuroendocrinology 2002, 14:555-560.
128. Irako T., Akamizu T., Hosoda H., Iwakura H., Ariyasu H., Tojo K., et al. Ghrelin prevents development of diabetes at adult age in streptozotocin-treated newborn rats. Diabetologia 2006, 49:1264-1273.
129. Soriano-Guillen L., Barrios V., Martos G., Chowen J.A., Campos-Barros A., Argente J. Effect of oral glucose administration on ghrelin levels in obese children. European Journal of Endocrinology/European Federation of Endocrine Societies 2004, 151:119-121.
130. Martos-Moreno G.A., Barrios V., Soriano-Guillen L., Argente J. Relationship between adiponectin levels, acylated ghrelin levels, and short-term body mass index changes in children with diabetes mellitus type 1 at diagnosis and after insulin therapy. European Journal of Endocrinology/European Federation of Endocrine Societies 2006, 155:757-761.
131. De Smet B., Mitselos A., Depoortere I. Motilin and ghrelin as prokinetic drug targets. Pharmacology & Therapeutics 2009, 123:207-223.
132. Tomasetto C., Karam S.M., Ribieras S., Masson R., Lefebvre O., Staub A., et al. Identification and characterization of a novel gastric peptide hormone: the motilin-related peptide. Gastroenterology 2000, 119:395-405.
133. Ang D., Nicolai H., Vos R., Mimidis K., Akyuz F., Kindt S., et al. Influence of ghrelin on the gastric accommodation reflex and on meal-induced satiety in man. Neurogastroenterology and Motility: The Official Journal of the European Gastrointestinal Motility Society 2009, 21:528-533. e528-529.
134. Levin F., Edholm T., Schmidt P.T., Gryback P., Jacobsson H., Degerblad M., et al. Ghrelin stimulates gastric emptying and hunger in normal-weight humans. The Journal of Clinical Endocrinology and Metabolism 2006, 91:3296-3302.
135. Avau B., Carbone F., Tack J., Depoortere I. Ghrelin signaling in the gut, its physiological properties, and therapeutic potential. Neurogastroenterology and Motility: The Official Journal of the European Gastrointestinal Motility Society 2013, 25:720-732.
136. Lall S., Tung L.Y., Ohlsson C., Jansson J.O., Dickson S.L. Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues. Biochemical and Biophysical Research Communications 2001, 280:132-138.
137. Chen H.Y., Trumbauer M.E., Chen A.S., Weingarth D.T., Adams J.R., Frazier E.G., et al. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 2004, 145:2607-2612.
138. Wang Q., Liu C., Uchida A., Chuang J.C., Walker A., Liu T., et al. Arcuate AgRP neurons mediate orexigenic and glucoregulatory actions of ghrelin. Molecular Metabolism 2014, 3:64-72.
139. Verhulst P.J., De Smet B., Saels I., Thijs T., Ver Donck L., Moechars D., et al. Role of ghrelin in the relationship between hyperphagia and accelerated gastric emptying in diabetic mice. Gastroenterology 2008, 135:1267-1276.
140. Sakkou M., Wiedmer P., Anlag K., Hamm A., Seuntjens E., Ettwiller L., et al. Arole for brain-specific homeobox factor Bsx in the control of hyperphagia and locomotory behavior. Cell Metabolism 2007, 5:450-463.
141. Theander-Carrillo C., Wiedmer P., Cettour-Rose P., Nogueiras R., Perez-Tilve D., Pfluger P., et al. Ghrelin action in the brain controls adipocyte metabolism. The Journal of Clinical Investigation 2006, 116:1983-1993.
142. Perez-Tilve D., Hofmann S.M., Basford J., Nogueiras R., Pfluger P.T., Patterson J.T., et al. Melanocortin signaling in the CNS directly regulates circulating cholesterol. Nature Neuroscience 2010, 13:877-882.
143. Perez-Tilve D., Heppner K., Kirchner H., Lockie S.H., Woods S.C., Smiley D.L., et al. Ghrelin-induced adiposity is independent of orexigenic effects. FASEB Journal: Official publication of the Federation of American Societies for Experimental Biology 2011, 25:2814-2822.
144. McFarlane M.R., Brown M.S., Goldstein J.L., Zhao T.J. Induced ablation of ghrelin cells in adult mice does not decrease food intake, body weight, or response to high-fat diet. Cell Metabolism 2014, 20:54-60.
145. Briggs D.I., Enriori P.J., Lemus M.B., Cowley M.A., Andrews Z.B. Diet-induced obesity causes ghrelin resistance in arcuate NPY/AgRP neurons. Endocrinology 2010, 151:4745-4755.
146. Briggs D.I., Lockie S.H., Wu Q., Lemus M.B., Stark R., Andrews Z.B. Calorie-restricted weight loss reverses high-fat diet-induced ghrelin resistance, which contributes to rebound weight gain in a ghrelin-dependent manner. Endocrinology 2013, 154:709-717.
147. Shrestha Y.B., Wickwire K., Giraudo S. Effect of reducing hypothalamic ghrelin receptor gene expression on energy balance. Peptides 2009, 30:1336-1341.
148. De Smet B., Depoortere I., Moechars D., Swennen Q., Moreaux B., Cryns K., et al. Energy homeostasis and gastric emptying in ghrelin knockout mice. The Journal of Pharmacology and Experimental Therapeutics 2006, 316:431-439.
149. Sun Y., Ahmed S., Smith R.G. Deletion of ghrelin impairs neither growth nor appetite. Molecular and Cellular Biology 2003, 23:7973-7981.
150. Wortley K.E., Anderson K.D., Garcia K., Murray J.D., Malinova L., Liu R., et al. Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:8227-8232.
151. Zigman J.M., Nakano Y., Coppari R., Balthasar N., Marcus J.N., Lee C.E., et al. Mice lacking ghrelin receptors resist the development of diet-induced obesity. The Journal of Clinical Investigation 2005, 115:3564-3572.
152. Longo K.A., Charoenthongtrakul S., Giuliana D.J., Govek E.K., McDonagh T., Qi Y., et al. Improved insulin sensitivity and metabolic flexibility in ghrelin receptor knockout mice. Regulatory Peptides 2008, 150:55-61.
153. Pfluger P.T., Kirchner H., Gunnel S., Schrott B., Perez-Tilve D., Fu S., et al. Simultaneous deletion of ghrelin and its receptor increases motor activity and energy expenditure. American Journal of Physiology Gastrointestinal and Liver Physiology 2008, 294:G610-G618.
154. Yamada G., Ariyasu H., Iwakura H., Hosoda H., Akamizu T., Nakao K., et al. Generation of transgenic mice overexpressing a ghrelin analog. Endocrinology 2010, 151:5935-5940.
155. Sun Y., Butte N.F., Garcia J.M., Smith R.G. Characterization of adult ghrelin and ghrelin receptor knockout mice under positive and negative energy balance. Endocrinology 2008, 149:843-850.
156. Szentirmai E., Kapas L., Sun Y., Smith R.G., Krueger J.M. The preproghrelin gene is required for the normal integration of thermoregulation and sleep in mice. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:14069-14074.
157. Sun Y., Asnicar M., Saha P.K., Chan L., Smith R.G. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metabolism 2006, 3:379-386.
158. Sun Y., Wang P., Zheng H., Smith R.G. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:4679-4684.
159. Mani B.K., Walker A.K., Lopez Soto E.J., Raingo J., Lee C.E., Perello M., et al. Neuroanatomical characterization of a growth hormone secretagogue receptor-green fluorescent protein reporter mouse. The Journal of Comparative Neurology 2014, 522:3644-3666.
160. Zigman J.M., Jones J.E., Lee C.E., Saper C.B., Elmquist J.K. Expression of ghrelin receptor mRNA in the rat and the mouse brain. The Journal of Comparative Neurology 2006, 494:528-548.
161. Shuto Y., Shibasaki T., Otagiri A., Kuriyama H., Ohata H., Tamura H., et al. Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity. The Journal of Clinical Investigation 2002, 109:1429-1436.
162. Rizza R.A., Mandarino L.J., Gerich J.E. Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes 1982, 31:663-669.
163. Kern A., Albarran-Zeckler R., Walsh H.E., Smith R.G. Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism. Neuron 2012, 73:317-332.
164. Muller T.D., Muller A., Yi C.X., Habegger K.M., Meyer C.W., Gaylinn B.D., et al. The orphan receptor Gpr83 regulates systemic energy metabolism via ghrelin-dependent and ghrelin-independent mechanisms. Nature Communications 2013, 4:1968.
165. Damian M., Marie J., Leyris J.P., Fehrentz J.A., Verdie P., Martinez J., et al. High constitutive activity is an intrinsic feature of ghrelin receptor protein: a study with a functional monomeric GHS-R1a receptor reconstituted in lipid discs. The Journal of Biological Chemistry 2012, 287:3630-3641.
166. Atalayer D., Gibson C., Konopacka A., Geliebter A. Ghrelin and eating disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2013, 40:70-82.
167. Heppner K.M., Muller T.D., Kirchner H., Perez-Tilve D., Pfluger P.T., Tschop M.H., et al. The role of ghrelin-octanoyl-acyl-transferase in thermoregulation. Journal of Endocrinological Investigation 2013, 36:180-184.
168. Goldstein J.L., Zhao T.J., Li R.L., Sherbet D.P., Liang G., Brown M.S. Surviving starvation: essential role of the ghrelin-growth hormone axis. Cold Spring Harbor Symposia on Quantitative Biology 2011, 76:121-127.
169. Li R.L., Sherbet D.P., Elsbernd B.L., Goldstein J.L., Brown M.S., Zhao T.J. Profound hypoglycemia in starved, ghrelin-deficient mice is caused by decreased gluconeogenesis and reversed by lactate or fatty acids. The Journal of Biological Chemistry 2012, 287:17942-17950.
170. Zhang Y., Fang F., Goldstein J.L., Brown M.S., Zhao T.J. Reduced autophagy in livers of fasted, fat-depleted, ghrelin-deficient mice: Reversal by growth hormone. Proceedings of the National Academy of Sciences of the United States of America 2015, 112:1226-1231.
171. Frayling T.M., Timpson N.J., Weedon M.N., Zeggini E., Freathy R.M., Lindgren C.M., et al. Acommon variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007, 316:889-894.
172. Dina C., Meyre D., Gallina S., Durand E., Korner A., Jacobson P., et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nature Genetics 2007, 39:724-726.
173. Hardy R., Wills A.K., Wong A., Elks C.E., Wareham N.J., Loos R.J., et al. Life course variations in the associations between FTO and MC4R gene variants and body size. Human Molecular Genetics 2010, 19:545-552.
174. Li H., Kilpelainen T.O., Liu C., Zhu J., Liu Y., Hu C., et al. Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia 2012, 55:981-995.
175. Lauria F., Siani A., Bammann K., Foraita R., Huybrechts I., Iacoviello L., et al. Prospective analysis of the association of a common variant of FTO (rs9939609) with adiposity in children: results of the IDEFICS study. PloS One 2012, 7:e48876.
176. Hinney A., Nguyen T.T., Scherag A., Friedel S., Bronner G., Muller T.D., et al. Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants. PloS One 2007, 2:e1361.
177. Cecil J.E., Tavendale R., Watt P., Hetherington M.M., Palmer C.N. An obesity-associated FTO gene variant and increased energy intake in children. The New England Journal of Medicine 2008, 359:2558-2566.
178. Speakman J.R., Rance K.A., Johnstone A.M. Polymorphisms of the FTO gene are associated with variation in energy intake, but not energy expenditure. Obesity (Silver Spring) 2008, 16:1961-1965.
179. Wardle J., Llewellyn C., Sanderson S., Plomin R. The FTO gene and measured food intake in children. International Journal of Obesity (London) 2009, 33:42-45.
180. Timpson N.J., Emmett P.M., Frayling T.M., Rogers I., Hattersley A.T., McCarthy M.I., et al. The fat mass- and obesity-associated locus and dietary intake in children. The American Journal of Clinical Nutrition 2008, 88:971-978.
181. Tanofsky-Kraff M., Han J.C., Anandalingam K., Shomaker L.B., Columbo K.M., Wolkoff L.E., et al. The FTO gene rs9939609 obesity-risk allele and loss of control over eating. The American Journal of Clinical Nutrition 2009, 90:1483-1488.
182. Wardle J., Carnell S., Haworth C.M., Farooqi I.S., O'Rahilly S., Plomin R. Obesity associated genetic variation in FTO is associated with diminished satiety. The Journal of Clinical Endocrinology and Metabolism 2008, 93:3640-3643.
183. den Hoed M., Westerterp-Plantenga M.S., Bouwman F.G., Mariman E.C., Westerterp K.R. Postprandial responses in hunger and satiety are associated with the rs9939609 single nucleotide polymorphism in FTO. The American Journal of Clinical Nutrition 2009, 90:1426-1432.
184. Karra E., O'Daly O.G., Choudhury A.I., Yousseif A., Millership S., Neary M.T., et al. Alink between FTO, ghrelin, and impaired brain food-cue responsivity. The Journal of Clinical Investigation 2013, 123:3539-3551.
185. Meyer K.D., Saletore Y., Zumbo P., Elemento O., Mason C.E., Jaffrey S.R. Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons. Cell 2012, 149:1635-1646.
186. Berulava T., Horsthemke B. The obesity-associated SNPs in intron 1 of the FTO gene affect primary transcript levels. European Journal of Human Genetics: EJHG 2010, 18:1054-1056.
187. Hess M.E., Hess S., Meyer K.D., Verhagen L.A., Koch L., Bronneke H.S., et al. The fat mass and obesity associated gene (Fto) regulates activity of the dopaminergic midbrain circuitry. Nature Neuroscience 2013, 16:1042-1048.
188. Diano S., Farr S.A., Benoit S.C., McNay E.C., da Silva I., Horvath B., et al. Ghrelin controls hippocampal spine synapse density and memory performance. Nature Neuroscience 2006, 9:381-388.
189. Kanoski S.E., Fortin S.M., Ricks K.M., Grill H.J. Ghrelin signaling in the ventral hippocampus stimulates learned and motivational aspects of feeding via PI3K-Akt signaling. Biological Psychiatry 2013, 73:915-923.
190. Kanoski S.E., Hayes M.R., Greenwald H.S., Fortin S.M., Gianessi C.A., Gilbert J.R., et al. Hippocampal leptin signaling reduces food intake and modulates food-related memory processing. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2011, 36:1859-1870.
191. Chuang J.C., Zigman J.M. Ghrelin's roles in stress, mood, and anxiety regulation. International Journal of Peptides 2010, 2010. pii: 460549.
192. Spencer S.J., Emmerzaal T.L., Kozicz T., Andrews Z.B. Ghrelin's role in the hypothalamic-pituitary-adrenal Axis stress Response: Implications for mood disorders. Biological Psychiatry 2014, pii: S0006-3223(14)00808-7.
193. Barim A.O., Aydin S., Colak R., Dag E., Deniz O., Sahin I. Ghrelin, paraoxonase and arylesterase levels in depressive patients before and after citalopram treatment. Clinical Biochemistry 2009, 42:1076-1081.
194. Kurt E., Guler O., Serteser M., Cansel N., Ozbulut O., Altinbas K., et al. The effects of electroconvulsive therapy on ghrelin, leptin and cholesterol levels in patients with mood disorders. Neuroscience Letters 2007, 426:49-53.
195. Dixit V.D., Yang H., Sun Y., Weeraratna A.T., Youm Y.H., Smith R.G., et al. Ghrelin promotes thymopoiesis during aging. The Journal of Clinical Investigation 2007, 117:2778-2790.
196. Szentirmai E., Kapas L., Krueger J.M. Ghrelin microinjection into forebrain sites induces wakefulness and feeding in rats. American Journal of Physiology Regulatory, Integrative and Comparative Physiology 2007, 292:R575-R585.
197. Szentirmai E., Kapas L., Sun Y., Smith R.G., Krueger J.M. Spontaneous sleep and homeostatic sleep regulation in ghrelin knockout mice. American Journal of Physiology Regulatory, Integrative and Comparative Physiology 2007, 293:R510-R517.
198. Andrews Z.B., Erion D., Beiler R., Liu Z.W., Abizaid A., Zigman J., et al. Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2009, 29:14057-14065.
199. Moon M., Kim H.G., Hwang L., Seo J.H., Kim S., Hwang S., et al. Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation. Neurotoxicity Research 2009, 15:332-347.
200. Walker A.K., Rivera P.D., Wang Q., Chuang J.C., Tran S., Osborne-Lawrence S., et al. The P7C3 class of neuroprotective compounds exerts antidepressant efficacy in mice by increasing hippocampal neurogenesis. Molecular Psychiatry 2014, 20:500-508.
201. Currie P.J., Khelemsky R., Rigsbee E.M., Dono L.M., Coiro C.D., Chapman C.D., et al. Ghrelin is an orexigenic peptide and elicits anxiety-like behaviors following administration into discrete regions of the hypothalamus. Behavioural Brain Research 2012, 226:96-105.
202. Olszewski P.K., Grace M.K., Billington C.J., Levine A.S. Hypothalamic paraventricular injections of ghrelin: effect on feeding and c-Fos immunoreactivity. Peptides 2003, 24:919-923.
203. van der Lely A.J., Tschop M., Heiman M.L., Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocrine Reviews 2004, 25:426-457.
204. Kola B., Farkas I., Christ-Crain M., Wittmann G., Lolli F., Amin F., et al. The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system. PloS One 2008, 3:e1797.
205. Anderson K.A., Ribar T.J., Lin F., Noeldner P.K., Green M.F., Muehlbauer M.J., et al. Hypothalamic CaMKK2 contributes to the regulation of energy balance. Cell Metabolism 2008, 7:377-388.
206. Kola B., Hubina E., Tucci S.A., Kirkham T.C., Garcia E.A., Mitchell S.E., et al. Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. The Journal of Biological Chemistry 2005, 280:25196-25201.
207. Lopez M., Lage R., Saha A.K., Perez-Tilve D., Vazquez M.J., Varela L., et al. Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metabolism 2008, 7:389-399.
208. Dietrich M.O., Antunes C., Geliang G., Liu Z.W., Borok E., Nie Y., et al. Agrp neurons mediate Sirt1's action on the melanocortin system and energy balance: roles for Sirt1 in neuronal firing and synaptic plasticity. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2010, 30:11815-11825.
209. Velasquez D.A., Martinez G., Romero A., Vazquez M.J., Boit K.D., Dopeso-Reyes I.G., et al. The central Sirtuin 1/p53 pathway is essential for the orexigenic action of ghrelin. Diabetes 2011, 60:1177-1185.
210. Andrews Z.B., Liu Z.W., Walllingford N., Erion D.M., Borok E., Friedman J.M., et al. UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals. Nature 2008, 454:846-851.
211. Lage R., Vazquez M.J., Varela L., Saha A.K., Vidal-Puig A., Nogueiras R., et al. Ghrelin effects on neuropeptides in the rat hypothalamus depend on fatty acid metabolism actions on BSX but not on gender. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 2010, 24:2670-2679.
212. Kwon Jeong J., Dae Kim J., Diano S. Ghrelin regulates hypothalamic prolyl carboxypeptidase expression in mice. Molecular Metabolism 2013, 2:23-30.
213. Martins L., Fernandez-Mallo D., Novelle M.G., Vazquez M.J., Tena-Sempere M., Nogueiras R., et al. Hypothalamic mTOR signaling mediates the orexigenic action of ghrelin. PloS One 2012, 7:e46923.
214. Faulconbridge L.F., Cummings D.E., Kaplan J.M., Grill H.J. Hyperphagic effects of brainstem ghrelin administration. Diabetes 2003, 52:2260-2265.
215. Faulconbridge L.F., Grill H.J., Kaplan J.M. Distinct forebrain and caudal brainstem contributions to the neuropeptide Y mediation of ghrelin hyperphagia. Diabetes 2005, 54:1985-1993.
216. Faulconbridge L.F., Grill H.J., Kaplan J.M., Daniels D. Caudal brainstem delivery of ghrelin induces fos expression in the nucleus of the solitary tract, but not in the arcuate or paraventricular nuclei of the hypothalamus. Brain Research 2008, 1218:151-157.
217. Alvarez-Crespo M., Skibicka K.P., Farkas I., Molnar C.S., Egecioglu E., Hrabovszky E., et al. The amygdala as a neurobiological target for ghrelin in rats: neuroanatomical, electrophysiological and behavioral evidence. PloS One 2012, 7:e46321.
218. Olszewski P.K., Li D., Grace M.K., Billington C.J., Kotz C.M., Levine A.S. Neural basis of orexigenic effects of ghrelin acting within lateral hypothalamus. Peptides 2003, 24:597-602.
219. Scott M.M., Perello M., Chuang J.C., Sakata I., Gautron L., Lee C.E., et al. Hindbrain ghrelin receptor signaling is sufficient to maintain fasting glucose. PloS One 2012, 7:e44089.
220. Bailey A.R., von Engelhardt N., Leng G., Smith R.G., Dickson S.L. Growth hormone secretagogue activation of the arcuate nucleus and brainstem occurs via a non-noradrenergic pathway. Journal of Neuroendocrinology 2000, 12:191-197.
221. Lawrence C.B., Snape A.C., Baudoin F.M., Luckman S.M. Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers. Endocrinology 2002, 143:155-162.
222. Date Y., Murakami N., Toshinai K., Matsukura S., Niijima A., Matsuo H., et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 2002, 123:1120-1128.
223. Arnold M., Mura A., Langhans W., Geary N. Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2006, 26:11052-11060.
224. Dornonville de la Cour C., Lindqvist A., Egecioglu E., Tung Y.C., Surve V., Ohlsson C., et al. Ghrelin treatment reverses the reduction in weight gain and body fat in gastrectomised mice. Gut 2005, 54:907-913.
225. Adachi S., Takiguchi S., Okada K., Yamamoto K., Yamasaki M., Miyata H., et al. Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study. Gastroenterology 2010, 138:1312-1320.
226. Dickson S.L., Egecioglu E., Landgren S., Skibicka K.P., Engel J.A., Jerlhag E. The role of the central ghrelin system in reward from food and chemical drugs. Molecular and Cellular Endocrinology 2011, 340:80-87.
227. Hansson C., Shirazi R.H., Naslund J., Vogel H., Neuber C., Holm G., et al. Ghrelin influences novelty seeking behavior in rodents and men. PloS One 2012, 7:e50409.
228. Jerlhag E., Egecioglu E., Landgren S., Salome N., Heilig M., Moechars D., et al. Requirement of central ghrelin signaling for alcohol reward. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:11318-11323.
229. Jerlhag E., Janson A.C., Waters S., Engel J.A. Concomitant release of ventral tegmental acetylcholine and accumbal dopamine by ghrelin in rats. PloS One 2012, 7:e49557.
230. Perello M., Sakata I., Birnbaum S., Chuang J.C., Osborne-Lawrence S., Rovinsky S.A., et al. Ghrelin increases the rewarding value of high-fat diet in an orexin-dependent manner. Biological Psychiatry 2010, 67:880-886.
231. Skibicka K.P., Hansson C., Alvarez-Crespo M., Friberg P.A., Dickson S.L. Ghrelin directly targets the ventral tegmental area to increase food motivation. Neuroscience 2011, 180:129-137.
232. Skibicka K.P., Shirazi R.H., Hansson C., Dickson S.L. Ghrelin interacts with neuropeptide Y Y1 and opioid receptors to increase food reward. Endocrinology 2012, 153:1194-1205.
233. Jerlhag E., Engel J.A. Ghrelin receptor antagonism attenuates nicotine-induced locomotor stimulation, accumbal dopamine release and conditioned place preference in mice. Drug and Alcohol Dependence 2011, 117:126-131.
234. Wellman P.J., Clifford P.S., Rodriguez J., Hughes S., Eitan S., Brunel L., et al. Pharmacologic antagonism of ghrelin receptors attenuates development of nicotine induced locomotor sensitization in rats. Regulatory Peptides 2011, 172:77-80.
235. Jerlhag E., Egecioglu E., Dickson S.L., Engel J.A. Ghrelin receptor antagonism attenuates cocaine- and amphetamine-induced locomotor stimulation, accumbal dopamine release, and conditioned place preference. Psychopharmacology 2010, 211:415-422.
236. Kawahara Y., Kaneko F., Yamada M., Kishikawa Y., Kawahara H., Nishi A. Food reward-sensitive interaction of ghrelin and opioid receptor pathways in mesolimbic dopamine system. Neuropharmacology 2013, 67:395-402.
237. Naleid A.M., Grace M.K., Cummings D.E., Levine A.S. Ghrelin induces feeding in the mesolimbic reward pathway between the ventral tegmental area and the nucleus accumbens. Peptides 2005, 26:2274-2279.
238. Quarta D., Di Francesco C., Melotto S., Mangiarini L., Heidbreder C., Hedou G. Systemic administration of ghrelin increases extracellular dopamine in the shell but not the core subdivision of the nucleus accumbens. Neurochemistry International 2009, 54:89-94.
239. Abizaid A., Liu Z.W., Andrews Z.B., Shanabrough M., Borok E., Elsworth J.D., et al. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. The Journal of Clinical Investigation 2006, 116:3229-3239.
240. Berridge K.C., Robinson T.E. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?. Brain Research Brain Research Reviews 1998, 28:309-369.
241. Salamone J.D., Correa M., Mingote S., Weber S.M. Nucleus accumbens dopamine and the regulation of effort in food-seeking behavior: implications for studies of natural motivation, psychiatry, and drug abuse. The Journal of Pharmacology and Experimental Therapeutics 2003, 305:1-8.
242. Blum I.D., Patterson Z., Khazall R., Lamont E.W., Sleeman M.W., Horvath T.L., et al. Reduced anticipatory locomotor responses to scheduled meals in ghrelin receptor deficient mice. Neuroscience 2009, 164:351-359.
243. Verhagen L.A., Egecioglu E., Luijendijk M.C., Hillebrand J.J., Adan R.A., Dickson S.L. Acute and chronic suppression of the central ghrelin signaling system reveals a role in food anticipatory activity. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology 2011, 21:384-392.
244. Carlini V.P., Monzon M.E., Varas M.M., Cragnolini A.B., Schioth H.B., Scimonelli T.N., et al. Ghrelin increases anxiety-like behavior and memory retention in rats. Biochemical and Biophysical Research Communications 2002, 299:739-743.
245. Skibicka K.P., Shirazi R.H., Rabasa-Papio C., Alvarez-Crespo M., Neuber C., Vogel H., et al. Divergent circuitry underlying food reward and intake effects of ghrelin: dopaminergic VTA-accumbens projection mediates ghrelin's effect on food reward but not food intake. Neuropharmacology 2013, 73C:274-283.
246. Romero-Pico A., Novelle M.G., Folgueira C., Lopez M., Nogueiras R., Dieguez C. Central manipulation of dopamine receptors attenuates the orexigenic action of ghrelin. Psychopharmacology 2013, 229:275-283.
247. Romero-Pico A., Vazquez M.J., Gonzalez-Touceda D., Folgueira C., Skibicka K.P., Alvarez-Crespo M., et al. Hypothalamic kappa-opioid receptor modulates the orexigenic effect of ghrelin. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2013, 38:1296-1307.
248. Ferrini F., Salio C., Lossi L., Merighi A. Ghrelin in central neurons. Current Neuropharmacology 2009, 7:37-49.
249. Liu Y., Wang P.S., Xie D., Liu K., Chen L. Ghrelin reduces injury of hippocampal neurons in a rat model of cerebral ischemia/reperfusion. The Chinese Journal of Physiology 2006, 49:244-250.
250. Horvath T.L., Abizaid A., Dietrich M.O., Li Y., Takahashi J.S., Bass J. Ghrelin-immunopositive hypothalamic neurons tie the circadian clock and visual system to the lateral hypothalamic arousal center. Molecular Metabolism 2012, 1:79-85.
251. Frecka J.M., Mattes R.D. Possible entrainment of ghrelin to habitual meal patterns in humans. American Journal of Physiology Gastrointestinal and Liver Physiology 2008, 294:G699-G707.
252. Monteleone P., Bencivenga R., Longobardi N., Serritella C., Maj M. Differential responses of circulating ghrelin to high-fat or high-carbohydrate meal in healthy women. The Journal of Clinical Endocrinology and Metabolism 2003, 88:5510-5514.
253. Zhao T.J., Sakata I., Li R.L., Liang G., Richardson J.A., Brown M.S., et al. Ghrelin secretion stimulated by {beta}1-adrenergic receptors in cultured ghrelinoma cells and in fasted mice. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:15868-15873.
254. Arosio M., Ronchi C.L., Beck-Peccoz P., Gebbia C., Giavoli C., Cappiello V., et al. Effects of modified sham feeding on ghrelin levels in healthy human subjects. The Journal of Clinical Endocrinology and Metabolism 2004, 89:5101-5104.
255. Callahan H.S., Cummings D.E., Pepe M.S., Breen P.A., Matthys C.C., Weigle D.S. Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans. The Journal of Clinical Endocrinology and Metabolism 2004, 89:1319-1324.
256. Tschop M., Weyer C., Tataranni P.A., Devanarayan V., Ravussin E., Heiman M.L. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001, 50:707-709.
257. Cummings D.E., Weigle D.S., Frayo R.S., Breen P.A., Ma M.K., Dellinger E.P., et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. The New England Journal of Medicine 2002, 346:1623-1630.
258. Müller T.D., Perez-Tilve D., Tong J., Pfluger P.T., Tschöp M.H. Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia. Journal of Cachexia, Sarcopenia and Muscle 2010, 1:159-167.
259. Shiiya T., Nakazato M., Mizuta M., Date Y., Mondal M.S., Tanaka M., et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. The Journal of Clinical Endocrinology and Metabolism 2002, 87:240-244.
260. Geliebter A., Gluck M.E., Hashim S.A. Plasma ghrelin concentrations are lower in binge-eating disorder. The Journal of Nutrition 2005, 135:1326-1330.
261. Kamiji M.M., Inui A. The role of ghrelin and ghrelin analogues in wasting disease. Current Opinion in Clinical Nutrition and Metabolic Care 2008, 11:443-451.
262. Korbonits M., Blaine D., Elia M., Powell-Tuck J. Metabolic and hormonal changes during the refeeding period of prolonged fasting. European Journal of Endocrinology/European Federation of Endocrine Societies 2007, 157:157-166.
263. Korbonits M., Blaine D., Elia M., Powell-Tuck J. Refeeding David Blaine-studies after a 44-day fast. The New England Journal of Medicine 2005, 353:2306-2307.
264. Espelund U., Hansen T.K., Hojlund K., Beck-Nielsen H., Clausen J.T., Hansen B.S., et al. Fasting unmasks a strong inverse association between ghrelin and cortisol in serum: studies in obese and normal-weight subjects. The Journal of Clinical Endocrinology and Metabolism 2005, 90:741-746.
265. Williams D.L., Grill H.J., Cummings D.E., Kaplan J.M. Vagotomy dissociates short- and long-term controls of circulating ghrelin. Endocrinology 2003, 144:5184-5187.
266. Cummings D.E., Clement K., Purnell J.Q., Vaisse C., Foster K.E., Frayo R.S., et al. Elevated plasma ghrelin levels in Prader Willi syndrome. Nature Medicine 2002, 8:643-644.
267. DelParigi A., Tschop M., Heiman M.L., Salbe A.D., Vozarova B., Sell S.M., et al. High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome. The Journal of Clinical Endocrinology and Metabolism 2002, 87:5461-5464.
268. Malandrino N., Miceli A., Leggio L., Mingrone G., Capristo E. High ghrelin levels in post-treatment euthyroid patients with Hashimoto's thyroiditis: a case-control preliminary study. Experimental and Clinical Endocrinology & Diabetes: Official Journal, German Society of Endocrinology [and] German Diabetes Association 2014, 122:540-543.
269. Buscher A.K., Cetiner M., Buscher R., Wingen A.M., Hauffa B.P., Hoyer P.F. Obesity in patients with Bardet-Biedl syndrome: influence of appetite-regulating hormones. Pediatric Nephrology 2012, 27:2065-2071.
270. Giordano R., Picu A., Pagotto U., De Iasio R., Bonelli L., Prodam F., et al. The negative association between total ghrelin levels, body mass and insulin secretion is lost in hypercortisolemic patients with Cushing's disease. European Journal of Endocrinology/European Federation of Endocrine Societies 2005, 153:535-543.
271. Libe R., Morpurgo P.S., Cappiello V., Maffini A., Bondioni S., Locatelli M., et al. Ghrelin and adiponectin in patients with Cushing's disease before and after successful transsphenoidal surgery. Clinical Endocrinology 2005, 62:30-36.
272. Koutkia P., Meininger G., Canavan B., Breu J., Grinspoon S. Metabolic regulation of growth hormone by free fatty acids, somatostatin, and ghrelin in HIV-lipodystrophy. American Journal of Physiology Endocrinology and Metabolism 2004, 286:E296-E303.
273. Bohdjalian A., Langer F.B., Shakeri-Leidenmuhler S., Gfrerer L., Ludvik B., Zacherl J., et al. Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin. Obesity Surgery 2010, 20:535-540.
274. Dimitriadis E., Daskalakis M., Kampa M., Peppe A., Papadakis J.A., Melissas J. Alterations in gut hormones after laparoscopic sleeve gastrectomy: a prospective clinical and laboratory investigational study. Annals of Surgery 2013, 257:647-654.
275. Hady H.R., Dadan J., Golaszewski P., Safiejko K. Impact of laparoscopic sleeve gastrectomy on body mass index, ghrelin, insulin and lipid levels in 100 obese patients. Wideochirurgia i inne techniki malo inwazyjne= Videosurgery and other miniinvasive techniques/kwartalnik pod patronatem Sekcji Wideochirurgii TChP oraz Sekcji Chirurgii Bariatrycznej TChP 2012, 7:251-259.
276. Kotidis E.V., Koliakos G.G., Baltzopoulos V.G., Ioannidis K.N., Yovos J.G., Papavramidis S.T. Serum ghrelin, leptin and adiponectin levels before and after weight loss: comparison of three methods of treatment-a prospective study. Obesity Surgery 2006, 16:1425-1432.
277. Langer F.B., Reza Hoda M.A., Bohdjalian A., Felberbauer F.X., Zacherl J., Wenzl E., et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obesity Surgery 2005, 15:1024-1029.
278. Lee W.J., Chen C.Y., Chong K., Lee Y.C., Chen S.C., Lee S.D. Changes in postprandial gut hormones after metabolic surgery: a comparison of gastric bypass and sleeve gastrectomy. Surgery for Obesity and Related Diseases: Official Journal of the American Society for Bariatric Surgery 2011, 7:683-690.
279. Peterli R., Steinert R.E., Woelnerhanssen B., Peters T., Christoffel-Courtin C., Gass M., et al. Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obesity Surgery 2012, 22:740-748.
280. Stefater M.A., Wilson-Perez H.E., Chambers A.P., Sandoval D.A., Seeley R.J. All bariatric surgeries are not created equal: insights from mechanistic comparisons. Endocrine Reviews 2012, 33:595-622.
281. Bose M., Machineni S., Olivan B., Teixeira J., McGinty J.J., Bawa B., et al. Superior appetite hormone profile after equivalent weight loss by gastric bypass compared to gastric banding. Obesity (Silver Spring) 2010, 18:1085-1091.
282. Uchida A., Zechner J.F., Mani B.K., Park W.M., Aguirre V., Zigman J.M. Altered ghrelin secretion in mice in response to diet-induced obesity and Roux-en-Y gastric bypass. Molecular Metabolism 2014, 3:717-730.
283. Chambers A.P., Kirchner H., Wilson-Perez H.E., Willency J.A., Hale J.E., Gaylinn B.D., et al. The effects of vertical sleeve gastrectomy in rodents are ghrelin independent. Gastroenterology 2013, 144:50-52. e55.
284. Hosoda H., Kangawa K. The autonomic nervous system regulates gastric ghrelin secretion in rats. Regulatory Peptides 2008, 146:12-18.
285. Broglio F., Gottero C., Van Koetsveld P., Prodam F., Destefanis S., Benso A., et al. Acetylcholine regulates ghrelin secretion in humans. The Journal of Clinical Endocrinology and Metabolism 2004, 89:2429-2433.
286. Simonian H.P., Kresge K.M., Boden G.H., Parkman H.P. Differential effects of sham feeding and meal ingestion on ghrelin and pancreatic polypeptide levels: evidence for vagal efferent stimulation mediating ghrelin release. Neurogastroenterology and Motility: The Official Journal of the European Gastrointestinal Motility Society 2005, 17:348-354.
287. Iwakura H., Ariyasu H., Hosoda H., Yamada G., Hosoda K., Nakao K., et al. Oxytocin and dopamine stimulate ghrelin secretion by the ghrelin-producing cell line, MGN3-1 invitro. Endocrinology 2011, 152:2619-2625.
288. Gagnon J., Anini Y. Insulin and norepinephrine regulate ghrelin secretion from a rat primary stomach cell culture. Endocrinology 2012, 153:3646-3656.
289. Nederkoorn C., Smulders F.T., Jansen A. Cephalic phase responses, craving and food intake in normal subjects. Appetite 2000, 35:45-55.
290. Monteleone P., Serritella C., Martiadis V., Maj M. Deranged secretion of ghrelin and obestatin in the cephalic phase of vagal stimulation in women with anorexia nervosa. Biological Psychiatry 2008, 64:1005-1008.
291. Crum A.J., Corbin W.R., Brownell K.D., Salovey P. Mind over milkshakes: mindsets, not just nutrients, determine ghrelin response. Health Psychology: Official Journal of the Division of Health Psychology, American Psychological Association 2011, 30:424-429. discussion 430-421.
292. Monteleone P., Serritella C., Scognamiglio P., Maj M. Enhanced ghrelin secretion in the cephalic phase of food ingestion in women with bulimia nervosa. Psychoneuroendocrinology 2010, 35:284-288.
293. Williams D.L., Cummings D.E., Grill H.J., Kaplan J.M. Meal-related ghrelin suppression requires postgastric feedback. Endocrinology 2003, 144:2765-2767.
294. Seoane L.M., Al-Massadi O., Barreiro F., Dieguez C., Casanueva F.F. Growth hormone and somatostatin directly inhibit gastric ghrelin secretion. An invitro organ culture system. Journal of Endocrinological Investigation 2007, 30:RC22-25.
295. Sakata I., Nakano Y., Osborne-Lawrence S., Rovinsky S.A., Lee C.E., Perello M., et al. Characterization of a novel ghrelin cell reporter mouse. Regulatory Peptides 2009, 155:91-98.
296. Foster-Schubert K.E., Overduin J., Prudom C.E., Liu J., Callahan H.S., Gaylinn B.D., et al. Acyl and total ghrelin are suppressed strongly by ingested proteins, weakly by lipids, and biphasically by carbohydrates. The Journal of Clinical Endocrinology and Metabolism 2008, 93:1971-1979.
297. Geliebter A., Carnell S., Gluck M.E. Cortisol and ghrelin concentrations following a cold pressor stress test in overweight individuals with and without night eating. International Journal of Obesity (London) 2013, 37:1104-1108.
298. Schellekens H., Finger B.C., Dinan T.G., Cryan J.F. Ghrelin signalling and obesity: at the interface of stress, mood and food reward. Pharmacology & Therapeutics 2012, 135:316-326.
299. Mundinger T.O., Cummings D.E., Taborsky G.J. Direct stimulation of ghrelin secretion by sympathetic nerves. Endocrinology 2006, 147:2893-2901.
300. de la Cour C.D., Norlen P., Hakanson R. Secretion of ghrelin from rat stomach ghrelin cells in response to local microinfusion of candidate messenger compounds: a microdialysis study. Regulatory Peptides 2007, 143:118-126.
301. Seoane L.M., Al-Massadi O., Caminos J.E., Tovar S.A., Dieguez C., Casanueva F.F. Sensory stimuli directly acting at the central nervous system regulate gastric ghrelin secretion. an exvivo organ culture study. Endocrinology 2007, 148:3998-4006.
302. Janssen S., Laermans J., Verhulst P.J., Thijs T., Tack J., Depoortere I. Bitter taste receptors and alpha-gustducin regulate the secretion of ghrelin with functional effects on food intake and gastric emptying. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:2094-2099.
303. Hass N., Schwarzenbacher K., Breer H. T1R3 is expressed in brush cells and ghrelin-producing cells of murine stomach. Cell and Tissue Research 2010, 339:493-504.
304. Al Massadi O., Lear P.V., Muller T.D., Lopez M., Dieguez C., Tschop M.H., et al. Review of novel aspects of the regulation of ghrelin secretion. Current Drug Metabolism 2014, 15:398-413.
305. Prudom C., Liu J., Patrie J., Gaylinn B.D., Foster-Schubert K.E., Cummings D.E., et al. Comparison of competitive radioimmunoassays and two-site sandwich assays for the measurement and interpretation of plasma ghrelin levels. The Journal of Clinical Endocrinology and Metabolism 2010, 95:2351-2358.
306. Engelstoft M.S., Park W.M., Sakata I., Kristensen L.V., Husted A.S., Osborne-Lawrence S., et al. Seven transmembrane G protein-coupled receptor repertoire of gastric ghrelin cells. Molecular Metabolism 2013, 2:376-392.
307. Sakata I., Park W.M., Walker A.K., Piper P.K., Chuang J.C., Osborne-Lawrence S., et al. Glucose-mediated control of ghrelin release from primary cultures of gastric mucosal cells. American Journal of Physiology Endocrinology and Metabolism 2012, 302:E1300-E1310.
308. Lu X., Zhao X., Feng J., Liou A.P., Anthony S., Pechhold S., et al. Postprandial inhibition of gastric ghrelin secretion by long-chain fatty acid through GPR120 in isolated gastric ghrelin cells and mice. American Journal of Physiology Gastrointestinal and Liver Physiology 2012, 303:G367-G376.
309. Gagnon J., Anini Y. Glucagon stimulates ghrelin secretion through the activation of MAPK and EPAC and potentiates the effect of norepinephrine. Endocrinology 2013, 154:666-674.
310. Iwakura H., Li Y., Ariyasu H., Hosoda H., Kanamoto N., Bando M., et al. Establishment of a novel ghrelin-producing cell line. Endocrinology 2010, 151:2940-2945.
311. Lefkowitz R.J., Stadel J.M., Caron M.G. Adenylate cyclase-coupled beta-adrenergic receptors: structure and mechanisms of activation and desensitization. Annual Review of Biochemistry 1983, 52:159-186.
312. Levitzki A. Beta-adrenergic receptors and their mode of coupling to adenylate cyclase. Physiological Reviews 1986, 66:819-854.
313. De Vriese C., Gregoire F., Lema-Kisoka R., Waelbroeck M., Robberecht P., Delporte C. Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites. Endocrinology 2004, 145:4997-5005.
314. Mizutani M., Atsuchi K., Asakawa A., Matsuda N., Fujimura M., Inui A., et al. Localization of acyl ghrelin- and des-acyl ghrelin-immunoreactive cells in the rat stomach and their responses to intragastric pH. American Journal of Physiology Gastrointestinal and Liver Physiology 2009, 297:G974-G980.
315. Blatnik M., Soderstrom C.I., Dysinger M., Fraser S.A. Prandial ghrelin attenuation provides evidence that des-acyl ghrelin may be an artifact of sample handling in human plasma. Bioanalysis 2012, 4:2447-2455.
316. Thompson N.M., Gill D.A., Davies R., Loveridge N., Houston P.A., Robinson I.C., et al. Ghrelin and des-octanoyl ghrelin promote adipogenesis directly invivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology 2004, 145:234-242.
317. Toshinai K., Yamaguchi H., Sun Y., Smith R.G., Yamanaka A., Sakurai T., et al. Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology 2006, 147:2306-2314.
318. Zhang W., Chai B., Li J.Y., Wang H., Mulholland M.W. Effect of des-acyl ghrelin on adiposity and glucose metabolism. Endocrinology 2008, 149:4710-4716.
319. Li L., Zhang L.K., Pang Y.Z., Pan C.S., Qi Y.F., Chen L., et al. Cardioprotective effects of ghrelin and des-octanoyl ghrelin on myocardial injury induced by isoproterenol in rats. Acta Pharmacologica Sinica 2006, 27:527-535.
320. Baldanzi G., Filigheddu N., Cutrupi S., Catapano F., Bonissoni S., Fubini A., et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. The Journal of Cell Biology 2002, 159:1029-1037.
321. Chen C.Y., Inui A., Asakawa A., Fujino K., Kato I., Chen C.C., et al. Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gastroenterology 2005, 129:8-25.
322. Broglio F., Gottero C., Prodam F., Gauna C., Muccioli G., Papotti M., et al. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. The Journal of Clinical Endocrinology and Metabolism 2004, 89:3062-3065.
323. Barazzoni R., Zanetti M., Ferreira C., Vinci P., Pirulli A., Mucci M., et al. Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome. The Journal of Clinical Endocrinology and Metabolism 2007, 92:3935-3940.
324. Cederberg H., Koivisto V.M., Jokelainen J., Surcel H.M., Keinanen-Kiukaanniemi S., Rajala U. Unacylated ghrelin is associated with changes in insulin sensitivity and lipid profile during an exercise intervention. Clinical Endocrinology 2012, 76:39-45.
325. Tong J., Davis H.W., Summer S., Benoit S.C., Haque A., Bidlingmaier M., et al. Acute administration of unacylated ghrelin has no effect on Basal or stimulated insulin secretion in healthy humans. Diabetes 2014, 63:2309-2319.
326. Asakawa A., Inui A., Fujimiya M., Sakamaki R., Shinfuku N., Ueta Y., et al. Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 2005, 54:18-24.
327. Delhanty P.J., Sun Y., Visser J.A., van Kerkwijk A., Huisman M., van Ijcken W.F., et al. Unacylated ghrelin rapidly modulates lipogenic and insulin signaling pathway gene expression in metabolically active tissues of GHSR deleted mice. PloS One 2010, 5:e11749.
328. Delhanty P.J., Huisman M., Baldeon-Rojas L.Y., van den Berge I., Grefhorst A., Abribat T., et al. Des-acyl ghrelin analogs prevent high-fat-diet-induced dysregulation of glucose homeostasis. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 2013, 27:1690-1700.
329. Granata R., Settanni F., Julien M., Nano R., Togliatto G., Trombetta A., et al. Des-acyl ghrelin fragments and analogues promote survival of pancreatic beta-cells and human pancreatic islets and prevent diabetes in streptozotocin-treated rats. Journal of Medicinal Chemistry 2012, 55:2585-2596.
330. Granata R., Settanni F., Biancone L., Trovato L., Nano R., Bertuzzi F., et al. Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3',5'-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-Kinase/Akt signaling. Endocrinology 2007, 148:512-529.
331. Granata R., Settanni F., Trovato L., Destefanis S., Gallo D., Martinetti M., et al. Unacylated as well as acylated ghrelin promotes cell survival and inhibit apoptosis in HIT-T15 pancreatic beta-cells. Journal of Endocrinological Investigation 2006, 29:RC19-22.
332. Granata R., Volante M., Settanni F., Gauna C., Ghe C., Annunziata M., et al. Unacylated ghrelin and obestatin increase islet cell mass and prevent diabetes in streptozotocin-treated newborn rats. Journal of Molecular Endocrinology 2010, 45:9-17.
333. Heppner K.M., Piechowski C.L., Muller A., Ottaway N., Sisley S., Smiley D.L., et al. Both acyl and des-acyl ghrelin regulate adiposity and glucose metabolism via central nervous system ghrelin receptors. Diabetes 2014, 63:122-131.
334. Carlini V.P., Varas M.M., Cragnolini A.B., Schioth H.B., Scimonelli T.N., de Barioglio S.R. Differential role of the hippocampus, amygdala, and dorsal raphe nucleus in regulating feeding, memory, and anxiety-like behavioral responses to ghrelin. Biochemical and Biophysical Research Communications 2004, 313:635-641.
335. Hewson A.K., Dickson S.L. Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats. Journal of Neuroendocrinology 2000, 12:1047-1049.
336. Schaeffer M., Langlet F., Lafont C., Molino F., Hodson D.J., Roux T., et al. Rapid sensing of circulating ghrelin by hypothalamic appetite-modifying neurons. Proceedings of the National Academy of Sciences of the United States of America 2013, 110:1512-1517.
337. Zorrilla E.P., Iwasaki S., Moss J.A., Chang J., Otsuji J., Inoue K., et al. Vaccination against weight gain. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:13226-13231.
338. Chapman I.M., Bach M.A., Van Cauter E., Farmer M., Krupa D., Taylor A.M., et al. Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects. The Journal of Clinical Endocrinology and Metabolism 1996, 81:4249-4257.
339. Murphy M.G., Plunkett L.M., Gertz B.J., He W., Wittreich J., Polvino W.M., et al. MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism. The Journal of Clinical Endocrinology and Metabolism 1998, 83:320-325.
340. Inoue H., Sakamoto Y., Kangawa N., Kimura C., Ogata T., Fujieda K., et al. Analysis of expression and structure of the rat GH-secretagogue/ghrelin receptor (Ghsr) gene: roles of epigenetic modifications in transcriptional regulation. Molecular and Cellular Endocrinology 2011, 345:1-15.
341. Bach M.A., Rockwood K., Zetterberg C., Thamsborg G., Hebert R., Devogelaer J.P., et al. The effects of MK-0677, an oral growth hormone secretagogue, in patients with hip fracture. Journal of the American Geriatrics Society 2004, 52:516-523.
342. Lainscak M., von Haehling S., Doehner W., Anker S.D. The obesity paradox in chronic disease: facts and numbers. Journal of Cachexia, Sarcopenia and Muscle 2012, 3:1-4.
343. von Haehling S., Morley J.E., Anker S.D. From muscle wasting to sarcopenia and myopenia: update 2012. Journal of Cachexia, Sarcopenia and Muscle 2012, 3:213-217.
344. Anker M.S., von Haehling S., Springer J., Banach M., Anker S.D. Highlights of the mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology. International Journal of Cardiology 2013, 162:73-76.
345. Miki K., Maekura R., Nagaya N., Nakazato M., Kimura H., Murakami S., et al. Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, placebo-controlled trial. PloS One 2012, 7:e35708.
346. Akashi Y.J., Palus S., Datta R., Halem H., Taylor J.E., Thoene-Reineke C., et al. No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure. International Journal of Cardiology 2009, 137:267-275.
347. Palus S., von Haehling S., Doehner W., Datta R., Zhang J., Dong J.Z., et al. Effect of application route of the ghrelin analog BIM-28131 (RM-131) on body weight and body composition in a rat heart failure model. International Journal of Cardiology 2013, 168:2369-2374.
348. Lenk K., Palus S., Schur R., Datta R., Dong J., Culler M.D., et al. Effect of ghrelin and its analogues, BIM-28131 and BIM-28125, on the expression of myostatin in a rat heart failure model. Journal of Cachexia, Sarcopenia and Muscle 2013, 4:63-69.
349. Vila G., Grimm G., Resl M., Heinisch B., Einwallner E., Esterbauer H., et al. B-type natriuretic peptide modulates ghrelin, hunger, and satiety in healthy men. Diabetes 2012, 61:2592-2596.
350. Lund L.H., Williams J.J., Freda P., LaManca J.J., LeJemtel T.H., Mancini D.M. Ghrelin resistance occurs in severe heart failure and resolves after heart transplantation. European Journal of Heart Failure 2009, 11:789-794.
351. Strassburg S., Anker S.D., Castaneda T.R., Burget L., Perez-Tilve D., Pfluger P.T., et al. Long-term effects of ghrelin and ghrelin receptor agonists on energy balance in rats. American Journal of Physiology Endocrinology and Metabolism 2008, 295:E78-E84.
352. Koch L. Growth hormone in health and disease: novel ghrelin mimetic is safe and effective as a GH stimulation test. Nature Reviews Endocrinology 2013, 9:315.
353. Currow D.C., Abernethy A.P. Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome. Future Oncology 2014, 10:789-802.
354. Camilleri M., Acosta A. Emerging treatments in Neurogastroenterology: relamorelin: a novel gastrocolokinetic synthetic ghrelin agonist. Neurogastroenterology and Motility: The Official Journal of the European Gastrointestinal Motility Society 2014, 27:324-332.
355. Sha L.V.d.P., L.H., Szurszewski J. Effects of RM-131 on circular smooth muscle in human and mouse colon and colonic Intraluminal pressure in conscious mice. Gastroenterology 2014, 146:S-363.
356. Shin A., Camilleri M., Busciglio I., Burton D., Smith S.A., Vella A., et al. The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitus. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association 2013, 11:1453-1459. e1454.
357. Shin A., Camilleri M., Busciglio I., Burton D., Stoner E., Noonan P., et al. Randomized controlled phase Ib study of ghrelin agonist, RM-131, in type 2 diabetic women with delayed gastric emptying: pharmacokinetics and pharmacodynamics. Diabetes Care 2013, 36:41-48.
358. Dass N.B., Munonyara M., Bassil A.K., Hervieu G.J., Osbourne S., Corcoran S., et al. Growth hormone secretagogue receptors in rat and human gastrointestinal tract and the effects of ghrelin. Neuroscience 2003, 120:443-453.
359. Deboer M.D. Use of ghrelin as a treatment for inflammatory bowel disease: mechanistic considerations. International Journal of Peptides 2011, 2011:189242.